August 7, 2015
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on August 6 calling for the revision of the package inserts for the anti-influenza drugs laninamivir (Daiichi Sankyo’s Inavir) and zanamivir (GlaxoSmithKline K.K.’s Relenza). The notification, issued to the...read more